These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3044722)

  • 21. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antihypertensive treatment in kidney diseases: whom, with what, how intensively?].
    Ritz E; Heidland A; Nowack R; Rambausek M
    Dtsch Med Wochenschr; 1990 Aug; 115(35):1325-8. PubMed ID: 2202580
    [No Abstract]   [Full Text] [Related]  

  • 23. The renin-angiotensin-aldosterone system in terminal renal failure.
    Weidmann P; Maxwell MH
    Kidney Int Suppl; 1975 Sep; ():S219-34. PubMed ID: 1104972
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic implications of converting-enzyme inhibitors in renal disease.
    Anderson S; Brenner BM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):81-7. PubMed ID: 3037894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertension and the renin-angiotensin system in the congenital hydronephrosis rat with non-obstructive pelviureteric junction abnormalities.
    Tauchi K; Kanehara H
    Exp Nephrol; 1996; 4(1):60-4. PubMed ID: 8788602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.
    Griffin KA; Bidani AK
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1054-65. PubMed ID: 17699327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of end-stage renal disease: a focus of antihypertensive therapy.
    Weir MR; Josselson J
    Md Med J; 1988 May; 37(5):369-72. PubMed ID: 3386421
    [No Abstract]   [Full Text] [Related]  

  • 28. [beta-blockers in hypertension with renal failure].
    Guédon J; Aubert P; Lucsko M; Chaignon M
    Nouv Presse Med; 1978 Sep; 7(31):2795-7. PubMed ID: 30967
    [No Abstract]   [Full Text] [Related]  

  • 29. [ACE inhibitors and the kidney].
    Hörl WH
    Wien Med Wochenschr; 1996; 146(11):231-4; discussion 234-5. PubMed ID: 8928521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
    Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
    Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of blood pressure-lowering treatment of essential hypertension on kidney vasculature and kidney function].
    Birkenhäger WH
    Verh K Acad Geneeskd Belg; 1994; 56(3):165-85; discussion 185-90. PubMed ID: 8053262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Plasma renin level and therapy in renal hypertension].
    Diekmann L; Bonzel KE; Jenett WD; Michelis K; Wagner H
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):373-5. PubMed ID: 876171
    [No Abstract]   [Full Text] [Related]  

  • 33. [Quantitative radiocardiographic studies of hemodynamics in patients with renoparenchymal hypertension].
    Stefanov S; Sheĭretova E
    Vutr Boles; 1982; 21(6):26-32. PubMed ID: 7164415
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of antihypertensive therapy on the course of renal failure.
    Lederle RM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S69-72. PubMed ID: 1283193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [May medical therapy of arterial hypertension by used in patients with renal failure?].
    Richet G; Ducrot H; Hamburger J; Legrain M; Maxwell M; Péquignot MH
    Presse Med (1893); 1968 Nov; 76(44):2103-6. PubMed ID: 5701039
    [No Abstract]   [Full Text] [Related]  

  • 36. [Medical treatment of hypertension in chronic kidney insufficiency].
    Vorburger C
    Schweiz Med Wochenschr; 1974 Jul; 104(27):946-50. PubMed ID: 4460232
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of arterial hypertension in non-oliguric renal failure].
    Beretta-Piccoli C
    Schweiz Med Wochenschr; 1989 Jul; 119(29):1016-22. PubMed ID: 2678436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Renal sequelae of sympathetic hyperactivity].
    Watschinger B; Habicht A
    Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
    Lifshits NL; Kutyrina IM
    Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.